PharmAla Files IP Protection For Novel MDXX Molecule: Viability As Autism Spectrum Treatment
Canadian biotech company PharmAla Biotech Holdings (OTC: PMBHF) has filed a patent covering composition of matter of Novel Chemical Entity (NCE) PharmAla-1.